SARS-COV-2 VACCINATION AND REPORTING POLICY (UPDATE 1)

[Tony]

UNCLASSIFIED//

ROUTINE

R 311611Z MAR 21 MID200000756466U

FM CNO WASHINGTON DC

TO NAVADMIN

INFO SECNAV WASHINGTON DC
CNO WASHINGTON DC

BT
UNCLAS

NAVADMIN 070/21

MSGID/GENADMIN/CNO WASHINGTON DC/CNO/MAR//

SUBJ/SARS-COV-2 VACCINATION AND REPORTING POLICY (UPDATE 1)//

REF/A/DOC/DHA/DHA-IPM/13DEC2020//
REF/B/DOC/DOD/23JUL2019//
REF/C/DOC/32 CFR PART 199.21/01DEC2016//
REF/D/DOC/FDA/EUA/11DEC2020
REF/E/DOC/CDC/DOC/13DEC2020
REF/F/DOC/OUSD/12DEC2020
REF/G/MSG/OPNAV/042056ZNOV20
REF/H/DOC/OPNAV/04MAR2021
REF/I/MSG/OPNAV/161751ZDEC20

NARR/REF A IS THE DEFENSE HEALTH AGENCY INTERIM PROCEDURES MEMORANDUM
20-004 DEPARTMENT OF DEFENSE (DOD) CORONAVIRUS DISEASE 2019 (COVID-19) 
VACCINATION IMPLEMENTATION PROGRAM.
REF B IS THE DODI 6025.02 INDIVIDUAL MEDICAL READINESS ADDRESSING 
RESPONSIBILITIES AND PROCEDURES FOR MONITORING INDIVIDUAL MEDICAL READINESS.
REF C IS 32 CFR PART 199.21, CIVILIAN HEALTH AND MEDICAL PROGRAM OF THE 
UNIFORMED SERVICES (CHAMPUS)/TRICARE:  TRICARE PHARMACY BENEFITS PROGRAM.
REF D IS THE FOOD AND DRUG ADMINISTRATION EMERGENCY USE AUTHORIZATION (EUA).
REF E IS THE ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES INTERIM 
RECOMMENDATION FOR USE OF PFIZER-BIONTECH COVID-19 VACCINE UNITED STATES, 
DECEMBER 2020.
REF F IS THE DEPARTMENT OF DEFENSE CORONAVIRUS-2019 VACCINATION PLAN (DOD
COVID-19 VACCINE PLAN).
REF G IS THE U.S. NAVY COVID-19 STANDARDIZED OPERATIONAL GUIDANCE VERSION 
4.0.
REF H IS THE UPDATED DOD AND NAVY POPULATION SCHEMA FOR VACCINATION PRIORITY 
VERSION 3.4 
REF I IS THE SARS-COV-2 VACCINATION AND REPORTING POLICY.// POC/ COVID-19 
CRISIS ACTION TEAM /(703)681-1125/

EMAIL:  USN.NCR.BUMEDFCHVA.MBX.BUMED-2019-NCOV-RESPONSE-CELL(AT)MAIL.MIL.

RMKS/1.  This NAVADMIN updates vaccine eligibility for Service members and 
their dependents executing an overseas permanent change of station (PCS).  
This change is in accordance with the updated DOD Population Schema (REF H) 
and modifies (REF I) to modify para 3.c and add para 3.g as follows:
Change paragraph 3.c:
Quote

3.c. SARS-CoV-2 Vaccine Priority.  The basic DOD schema is:
Tier 1a:  Healthcare and Emergency Service personnel.
Tier 1b:  Critical national capabilities, personnel forward deployed to 
austere locations, personnel preparing to deploy overseas, beneficiaries 75-
years-old and above.
Tier 1c:  Beneficiaries between 64 and 75-years-old, high-risk beneficiaries, 
personnel deployed/TDY OCONUS for over 30 days, essential workers not 
previously mentioned.
Tier 2:  Healthy uniformed personnel and population beneficiaries.
Unquote.
Change paragraph 3.c.1:
Quote:

3.c.1. Tier 1a is nearly complete.  Tier 1b will extend through April 2021.
Tier 1c will begin in April.  These dates are subject to change based on 
vaccine production.
Unquote.
To lessen the burden on overseas MTFs, ease logistics chains regarding 
overseas vaccine distribution, and aide Service members with navigating 
widely disparate foreign requirements, add paragraph 3.g:
Quote

3.g. Service members and their eligible dependents will be prioritized to 
receive the SARS-CoV-2 vaccine prior to executing an overseas PCS during the 
overseas screening process at their affiliated MTF.  Ensure vaccination 
timeline incorporates full immunization prior to travel.
Unquote.

2.  Released by VADM P. G. Sawyer, Deputy Chief of Naval Operations for 
Operations, Plans and Strategy, OPNAV N3/N5.//

BT
#0001
NNNN
UNCLASSIFIED//